Scaffold Therapeutics

Scaffold Therapeutics is a biotechnology startup founded in 2022 with the slogan "Drug discovery in mRNA modification." The company is focused on leveraging generative AI models to develop small molecules that regulate pathogenic mRNA activity. In January 2024, Scaffold Therapeutics secured a Seed Round investment from Iaso Ventures. The company is based in the United States. With its innovative approach to drug discovery and mRNA modification, Scaffold Therapeutics has attracted the attention of venture capital firms like Iaso Ventures, opening up opportunities for further growth and development in the biotechnology industry.